Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations.

Gut - 1 Jun 2016

Gougelet Angélique, Sartor Chiara, Bachelot Laura, Godard Cécile, Marchiol Carmen, Renault Gilles, Tores Frédéric, Nitschke Patrick, Cavard Catherine, Terris Benoit, Perret Christine, Colnot Sabine

Abstract excerpt

OBJECTIVE: Hepatocellular carcinoma (HCC) is the most prevalent primary tumour of the liver. About a third of these tumours presents activating mutations of the β-catenin gene. The molecular pathogenesis of HCC has been elucidated, but mortality remains high, and new therapeutic approaches, inclu...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to beta Catenin
Share to Carcinoma, Hepatocellular
Share to Cyclin D1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Liver Neoplasms

Share to Liver Neoplasms, Experimental

Share to MicroRNAs

Share to Mutation

Source

Identifiers

PMID: 25792709
DOI: 10.1136/gutjnl-2014-308969

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25792709-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations.PMID 25792709Read ↗

Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model.Semantic proximity Read ↗

Targeting Signalling Pathways in Hepatocellular CarcinomaSemantic proximity Read ↗

Wnt/β-Catenin Signaling in Liver CancersSemantic proximity Read ↗

Targeting β‐catenin in hepatocellular cancers induced by coexpression of mutant β‐catenin and K‐Ras in miceSemantic proximity Read ↗

MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancerSemantic proximity Read ↗

siRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survival.Semantic proximity Read ↗

Identification of Ppar γ -modulated miRNA hubs that target the fibrotic tumor microenvironmentSemantic proximity Read ↗

Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.Semantic proximity Read ↗

The ß-catenin-target Fascin-1, altering hepatocyte differentiation, is a new marker of immature cells in hepatoblastomasSemantic proximity Read ↗

β‐catenin deficiency in hepatocytes aggravates hepatocarcinogenesis driven by oncogenic β‐catenin and METSemantic proximity Read ↗

New three-dimensional preclinical models to understand and treat liver cancers activated for the β-catenin pathwaySemantic proximity Read ↗

Cooperation between MYC and β-catenin in liver tumorigenesis requires Yap/TazSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.